Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy

Patients with acute myeloid leukemia (AML) are often exposed to broad-spectrum antibiotics and thus at high risk of Clostridioides difficile infections (CDI). As bacterial infections are a common cause for treatment-related mortality in these patients, we conducted a retrospective study to analyze t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballo, Olivier, Kreisel, Eva-Maria, Eladly, Fagr, Brunnberg, Uta, Stratmann, Jan, Hunyady, Peter, Hogardt, Michael, Wichelhaus, Thomas A., Kempf, Volkhard A. J., Steffen, Björn, Vehreschild, Joerg J., Vehreschild, Maria J. G. T., Finkelmeier, Fabian, Serve, Hubert, Brandts, Christian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536157/
https://www.ncbi.nlm.nih.gov/pubmed/32974837
http://dx.doi.org/10.1007/s00277-020-04274-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536157/
https://www.ncbi.nlm.nih.gov/pubmed/32974837
http://dx.doi.org/10.1007/s00277-020-04274-1

Ejemplares similares